Malignant tumor of testis: genes and variants
Explore variant evidence for Malignant tumor of testis across 3 analyzed proteins (STK11, BCL10, KIT). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 11 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Malignant tumor of testis
STK11: Serine/threonine-protein kinase STK11
It activates AMPK-family kinases to coordinate cellular energy sensing, polarity, and growth restraint. Germline loss-of-function variants cause Peutz-Jeghers syndrome and its associated cancer predisposition, while somatic loss is common in lung and other cancers.
1 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in STK11 have source records linked to Malignant tumor of testis. Association strength is not clinical gene validity.
BCL10: B-cell lymphoma/leukemia 10
It forms part of the CARD11-BCL10-MALT1 signaling complex that couples antigen-receptor activation to NF-kappaB signaling in lymphocytes. Biallelic loss can cause combined immunodeficiency, while dysregulated signaling contributes to certain lymphomas.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BCL10 have source records linked to Malignant tumor of testis. Association strength is not clinical gene validity.
KIT: Mast/stem cell growth factor receptor Kit
Stem-cell-factor signaling through this pathway supports hematopoietic progenitors, mast cells, melanocytes, and germ cells. Activating variants drive gastrointestinal stromal tumors, systemic mastocytosis, and other malignancies, whereas loss-of-function variants can cause piebaldism.
0 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in KIT have source records linked to Malignant tumor of testis. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Malignant tumor of testis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| STK11 S240W | 240 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| BCL10 T163M | 163 | Pathogenic / likely pathogenic |
Same protein, different disease
- Peutz-Jeghers syndrome also has ClinVar records linked to STK11 variants; they fall mostly in different places as the Malignant tumor of testis variants (24 pathogenic / likely pathogenic).
- Melanoma, cutaneous malignant also has ClinVar records linked to STK11 variants; they fall mostly in different places as the Malignant tumor of testis variants (4 pathogenic / likely pathogenic).
Diseases related to Malignant tumor of testis
- Germ cell tumor of testis, also linked to BCL10, KIT and STK11
- Gastrointestinal stromal tumor, also linked to KIT
- Ovarian cancer, also linked to KIT
- Acute myeloid leukemia, also linked to KIT
- Peutz-Jeghers syndrome, also linked to STK11
- Hereditary breast ovarian cancer syndrome, also linked to STK11
- Colorectal cancer, also linked to KIT
- Non-small cell lung carcinoma, also linked to STK11
- Melanoma, cutaneous malignant, also linked to STK11
- Lung adenocarcinoma, also linked to STK11
- Piebaldism, also linked to KIT
- Hepatocellular carcinoma, also linked to KIT
Frequently asked questions
Which genes have records linked to Malignant tumor of testis?
This view contains 3 analyzed proteins: STK11, BCL10, KIT. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 19 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center